{
    "eid": "2-s2.0-85011305866",
    "title": "Pharmacokinetics of a new, nasal formulation of naloxone",
    "cover-date": "2017-05-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        }
    ],
    "keywords": [
        "Bioavailability",
        "Intranasal",
        "Naloxone",
        "Nasal",
        "Overdose",
        "Pharmacokinetics"
    ],
    "authors": [
        "Ida Tylleskar"
    ],
    "citedby-count": 32,
    "ref-count": 35,
    "ref-list": [
        "Extent of illicit drug use and dependence, and their contribution to the global burden of disease",
        "The ratio of non-fatal to fatal heroin overdose [2] (multiple letters)",
        "Management of opioid analgesic overdose",
        "Health Products Regulatory Authority Naloxone 400 micrograms/ml solution for injection/infusion - Summary of Product Characteristics",
        "Naloxone in opioid poisoning: Walking the tightrope",
        "Adverse events after naloxone treatment of episodes of suspected acute opioid overdose",
        "Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose",
        "Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose",
        "Experience of non-fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions",
        "Community management of opioid overdose, WHO guidelines approved by the guidelines review committee",
        "Emerg Med Int",
        "Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014",
        "Nasal absorption of naloxone and buprenorphine in rats",
        "Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action",
        "NARCAN\u00ae (naloxone hydrochloride) nasal spray - Patient Information Leaflet",
        "Disposition of nasal, intravenous, and oral methadone in healthy volunteers",
        "Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery",
        "Intranasal midazolam: A comparison of two delivery devices in human volunteers",
        "Nasal administration of opioids for pain management in adults",
        "Intranasal delivery: Physicochemical and therapeutic aspects",
        "Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers",
        "Naloxone for outpatient use: data required to support an NDA",
        "FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose",
        "Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose",
        "Intranasal naloxone for the treatment of suspected heroin overdose",
        "Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose",
        "Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting",
        "Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: Imaginative shortcut or dangerous bypass of essential safety procedures?",
        "Application issues in bioanalytical method validation, sample analysis and data reporting",
        "Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies - Conference Report",
        "The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers",
        "Intranasal drug delivery: How, why and what for?",
        "Pitfalls of intranasal naloxone",
        "Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose",
        "Evzio prescribing information"
    ],
    "affiliation": [
        {
            "affiliation-city": "Oslo",
            "affilname": "Oslo Universitetssykehus",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Trondheim",
            "affilname": "Universitetssykehuset i Trondheim",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Trondheim",
            "affilname": "Norges Teknisk-Naturvitenskapelige Universitet",
            "affiliation-country": "Norway"
        }
    ],
    "funding": [
        "Laerdal Foundation for Acute Medicine"
    ]
}